Search

Your search keyword '"Triggiani, L"' showing total 308 results

Search Constraints

Start Over You searched for: Author "Triggiani, L" Remove constraint Author: "Triggiani, L"
308 results on '"Triggiani, L"'

Search Results

2. Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis

5. Stereotactic prostate radiotherapy with or without androgen deprivation therapy: A phase III, multi-institutional randomized-controlled trial. The SPA trial

6. Stereotactic body radiation therapy and abiraterone acetate for patients affected by oligometastatic castrate-resistant prostate cancer: Freedom from biochemical, radiological progression free survival and freedom from following treatment approaches within a randomized phase II trial (ARTO – NCT03449719)

7. Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health—the BLADE study

8. PO-1491 Profiling PCa patients with BCR in the era of early imaging detection: an AIRO-URO group study

9. PO-1494 Process mining in PCa Salvage RT patients care path: an AIRO-URO group preliminary analysis

10. Editorial: Reviews in genitourinary oncology

11. How has prostate cancer radiotherapy changed in Italy between 2004 and 2011? An analysis of the national patterns-of-practice (pop) database by the uro-oncology study group of the italian society of radiotherapy and clinical oncology (airo)

12. How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study

13. Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study)

14. Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study

17. Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)

18. Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study)

19. Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)

20. Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study)

21. Concomitant immuno-radiotherapy in metastatic renal cell carcinoma: multicenter analysis

22. Impact of Gastrointestinal Side Effects on Patients’ Reported Quality of Life Trajectories after Radiotherapy for Prostate Cancer: Data from the Prospective, Observational Pros-IT CNR Study

23. PD-0765 Bowel bother and function after RT for prostate cancer : the prospective QoL Pros-IT CNR study

24. PO-1366 Pattern of recurrence after SBRT in prostate cancer patients with nodal pelvic relapse

25. PO-1037 Hypofractionated Radiation Therapy For Non-Elderly Patients With Glioblastoma

27. PD-0849 Concomitant Nivolumab and RT in metastatic kidney cancer. Benefit of ablative vs palliative approach

28. PO-1347 Prostate cancer RT pattern of practice in Italy between 2004-2011: an analysis by the AIRO database

30. P104 - Stereotactic body radiation therapy and abiraterone acetate for patients affected by oligometastatic castrate-resistant prostate cancer: Freedom from biochemical, radiological progression free survival and freedom from following treatment approaches within a randomized phase II trial (ARTO – NCT03449719)

31. P032 - Stereotactic prostate radiotherapy with or without androgen deprivation therapy: A phase III, multi-institutional randomized-controlled trial. The SPA trial

37. Metastasis-directed Stereotactic Body Radiotherapy (SBRT)-guided by pet-ct 18f-choline versus pet-ct 68ga-psma in castration sensitive oligorecurrent prostate cancer: A comparative effectiveness analysis

38. PH-0038: RT and concomitant CDDP vs cetuximab for head and neck cancer: long term outcomes of a randomized PH. II trial

39. PO-1193: 18F-CHOLINE PET/68Ga-PSMA PET SBRT in oligorecurrent prostate cancer: comparative analysis

41. PO-1192: Elective Pelvic Nodes Irradiation in Patients with Prostate Cancer (PRO-EPI Study)

42. 678P Metastasis-directed stereotactic body radiotherapy (SBRT)-guided by PET-CT 18F-choline versus PET-CT 68Ga-PSMA in castration sensitive oligorecurrent prostate cancer: A comparative effectiveness analysis

43. Note sul Merck & Elsevier Young Chemists Symposium 2018

44. Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO)

46. Linee Guida AIRO-AIRB 2018: Neoplasie della Vescica

47. NOTE SUL MERCK YOUNG CHEMISTS SYMPOSIUM 2017

49. Preliminary result of a pilot phase IV study to evaluate variations in bone mineral density and lean and fat body mass, measured by dual-energy X-ray absorptiometry in patients with prostate cancer without bone metastases treated with degarelix

50. Comparing stereotactic body radiotherapy and elective nodal radiotherapy in the management of nodal oligorecurrent prostate cancer: A multi-institutional analysis

Catalog

Books, media, physical & digital resources